AMEX · DSS

DSS, Inc.

$0.55 -$0.01 (-2.14%) 1D Market open

Key Metrics

$5.64M
Market cap
P/E · TTM
$20.13M
Revenue · TTM
−$24.45M
Net income
EPS · TTM $-2.82
Dividend yield
Free cash flow
Beta · 1Y -0.03
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +33.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • Jun 8
    From its Feb 3 high, the share price fell 70%.

    Peak close $1.39 on Feb 3; trough close $0.42 on Jun 8. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -70%
  • Feb 4
    The stock moved -32.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.64M
Enterprise value$2.93M
Shares outstanding10.0M
52-wk range$0.36 – $1.90
Avg volume · 20D122.2K
Net cash $2.72M
Book value / share$0.39
IndustryPaperboard Containers & Boxes
ExchangeAMEX
About DSS, Inc.
IPO dateFeb 1, 1995
Employees102

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.28
P/FCF
EV/EBITDA
EV/Sales0.15
Graham №

Profitability

Gross
Operating -141.4%
Net -121.4%
FCF
ROE / ROIC -207.1% · -965.0%

Financial Health

Current ratio0.22
Quick ratio0.19
Debt / equity1.63
Debt / EBITDA
Net cash $2.72M
Working capital−$37.00M

Cash Flow · TTM

Operating CF −$7.62M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-8.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings